Work

A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.3026

Authors: Jacob Stephen Thomas, Diane Habib, Diana L. Hanna, Christina Linda Antoine Nakhoul, Anastasia Martynova, Syma Iqbal, Jorge J. Nieva, Denice D. Tsao-Wei, Ming Hsieh, Ray Yin, Anthony B. El-Khoueiry

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center, ANP Technologies (United States)

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379283221

Cites:

Cited by:

Related to: 10